The effort is already bearing fruit, as the team has been able to validate several variants known to be connected with adverse drug reactions.
NEW YORK (GenomeWeb News) – Agilent Technologies announced that it and a team of researchers from six organizations are developing models for toxicology testing with a $6 million grant from the National Institutes of Health.
RainDance is partnering with Roche 454 and Ambry in two separate alliances aimed at developing ADME gene screening panels for use on next-generation sequencing instruments.
The partners aim to develop a transporter-based assay system capable of predicting absorption, distribution, metabolism, and excretion of drug candidates.
The lawsuit claims that Invitrogen and CellzDirect are infringing a Celsis patent that relates to processes and methods for producing cryopreserved hepatocytes.
The Seoul-based life sciences firm will provide an array of services to help develop biological assays for cancer and endocrine disorders.
The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.
The Associated Press reports that gene-edited food may soon be for sale.
The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.
In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.